The MHRA's special web-based system for reporting adverse reactions to swine flu medicines has been extended. The Swine Flu ADR Portal can now be used to notify the MHRA of adverse events following exposure to vaccines against H1N1 (Celvapan and Pandemrix) or seasonal flu, in addition to reporting adverse reactions to Tamiflu and Relenza.
Swine flu ADR portal
01 December 2009, 3:25pm
All Comments
There are currently no comments.
You must log in to comment on articles.
New users can register here free for full access.
Related Drug Categories
GP Curriculum Centre
Educational resource for the learning and teaching of the
GP curriculum
Deleted products
Cumulative list of products discontinued from the UK market
in 2010
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
